octanoic acid has been researched along with Alloxan Diabetes in 9 studies
octanoic acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #1764
octanoic acid : A straight-chain saturated fatty acid that is heptane in which one of the hydrogens of a terminal methyl group has been replaced by a carboxy group. Octanoic acid is also known as caprylic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aminocarnitine has a strong hypoglycemic effect in fasted diabetic mice; a single dose (0." | 1.27 | Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines. ( Griffith, OW; Jenkins, DL, 1986) |
| "Octanoic acid is a medium chain fatty acid, whose oxidation is not dependent on the carnitine transferase system and is not inhibited by TDGA." | 1.27 | Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse (db/db). ( Bahl, JJ; Bressler, R; Lee, SM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, K | 1 |
| Ghosh, M | 1 |
| Barrena, HC | 1 |
| Gazola, VA | 1 |
| Furlan, MM | 1 |
| Garcia, RF | 1 |
| de Souza, HM | 1 |
| Bazotte, RB | 1 |
| LOSSOW, WJ | 1 |
| BROWN, GW | 1 |
| CHAIKOFF, IL | 1 |
| Chen, V | 1 |
| Wagner, G | 1 |
| Spitzer, JJ | 1 |
| Grill, V | 1 |
| Sako, Y | 1 |
| Ostenson, CG | 1 |
| Jalkanen, P | 1 |
| Barbee, RW | 1 |
| Shepherd, RE | 1 |
| Burns, AH | 1 |
| Jenkins, DL | 1 |
| Griffith, OW | 1 |
| Pahl-Wostl, C | 1 |
| Seelig, J | 1 |
| Lee, SM | 1 |
| Bahl, JJ | 1 |
| Bressler, R | 1 |
9 other studies available for octanoic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Structured DAG oil ameliorates renal injury in streptozotocin-induced diabetic rats through inhibition of NF-κB and activation of Nrf2 pathway.
Topics: Acute Kidney Injury; Animals; Caprylates; Diabetes Mellitus, Experimental; Diglycerides; Immunoblott | 2017 |
Ketogenesis evaluation in perfused liver of diabetic rats submitted to short-term insulin-induced hypoglycemia.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Blood Glucose; Caprylates; Diabetes Mellitus, Experim | 2009 |
The action of insulin in sparing fatty acid oxidation: a study with palmitic acid-1-C14 and octanoate-1-C14.
Topics: Animals; Caprylates; Diabetes Mellitus, Experimental; Fatty Acids; Insulin; Lipid Metabolism; Oxidat | 1956 |
Regulation of substrate oxidation in isolated myocardial cells by beta-hydroxybutyrate.
Topics: 3-Hydroxybutyric Acid; Animals; Caprylates; Cells, Cultured; Diabetes Mellitus, Experimental; Hydrox | 1984 |
Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Caprylates; Diabetes Mellitus, Experimental; | 1991 |
T3 treatment does not prevent myocardial dysfunction in chronically diabetic rats.
Topics: Animals; Caprylates; Cytochrome c Group; Diabetes Mellitus, Experimental; Half-Life; Heart Diseases; | 1988 |
Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
Topics: Acyltransferases; Animals; Betaine; Blood Glucose; Caprylates; Carnitine; Carnitine O-Palmitoyltrans | 1986 |
Ketogenesis in the living rat followed by 13C-NMR spectroscopy. Infusion of [1,3-13C]octanoate.
Topics: Animals; Caprylates; Diabetes Mellitus, Experimental; Fasting; Ketone Bodies; Liver; Magnetic Resona | 1987 |
Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse (db/db).
Topics: Animals; Blood Glucose; Caprylates; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Interac | 1985 |